European Pharma Days

Join Bruker for the annual European Pharma Meeting taking place on April 15th – 16th 2026 in Mannheim, Germany, organized by Bruker and TH Mannheim’s M²Aind industry consortium and CeMOS Research and Transfer Center.

Discover Innovation at the Forefront of Pharmaceutical Research

Join us for an inspiring two day in-person European Pharma Days event, bringing together leading experts from the pharmaceutical industry and academia. Experience how state of the art mass spectrometry and imaging technologies are accelerating progress in pharmaceutical and clinical research.

What to expect:

• Insightful talks highlighting how ESI  and MALDI based MS approaches and innovative imaging technologies drive innovation across drug discovery and clinical research.
• In depth presentations on biologics characterization, featuring Top Down and HDX MS strategies for elucidating structure and dynamics.
• Comprehensive coverage of omics workflows, including metabolomics, lipidomics, and proteomics (metaproteomics and glycoproteomics), demonstrating the analytical power of TIMS enabled in-depth research.
• Dedicated presentations on small molecule characterisation, including the capabilities of MSⁿ eXd for structural elucidation.
• Cutting edge MALDI Imaging (MSI) research, illustrating the remarkable breadth of this technology—from drug formulation and lipid mapping in tissue, to tumor research combining MSI with mid infrared tissue characterization, and advanced 3D cell culture models.

Network, Learn, and Connect

The event will take place in a safe, comfortable, and collaborative environment, offering ample time for networking and scientific exchange. Connect with speakers, peers, and technology partners during extended breaks and in the exhibition area.

Location:

MAFINEX Technologiezentrum
Julius-Hatry-Straße 1
68163 Mannheim, Germany

Participation is free of charge, but seats are limited.

Day 1: Wednesday, April 15, 2026

10:30 Registration Open

11:00 - 11:20 Opening 
Prof. Angelika Altmann-Dieses, Ph.D., President, Mannheim University of Applied Sciences, Mannheim, Germany
Prof. Dr. Carsten Hopf, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
Dr. Christian Albers, Business Development Manager, Pharmaceutical Markets, DACH/Nordics, Bruker Daltonics, Bremen, Germany

11:20 - 11:45 Use of timsTOF for Omics approaches
Frédéric M. Vaz, Ph.D., Head Core Facility Metabolomics, Associate Professor, Amsterdam UMC, Amsterdam, The Netherlands

11:45 - 12:10 A Scalable Microbial Platform for CNS Therapeutic Discovery and Development
Jie Zhang, Ph.D., Co-Founder & CTO, Biomia Aps, Copenhagen, Denmark

12:10 - 12:35 Small molecule structure elucidation by MS2/MS3 EID/CID on timsOMNI and building and using multiple AI models from timsTOF data - How to Train a Dragon
Gustaf Hulthe, Ph.D., Pharmaceutical Technology and Development, AstraZeneca, Gothenburg, Sweden

12:35 - 14:05 Lunch Break

14:05 - 14:30 Spatial Control of Immune Cell Activation by Lipid–Protein Signaling Networks
Daniel Engel, Ph.D., Professor, Department of Immunodynamics, Medical Research Center, University Hospital Essen, Germany

14:30 - 14:55 Mid-infrared imaging-based tumor annotation for spatial lipidomic biomarker discovery via MALDI imaging
Miriam Rittel, MSc., Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

14:55 - 15:20 From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Analysis of 3D Cell Culture Disease Models
Stefania Alexandra Iakab, Postdoctoral Researcher, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

15:20 - 16:00 Coffee Break 

16:00 - 16:25 Pushing the boundaries of biotherapeutic characterization with the timsOmni
Julia Chamot-Rooke, Ph.D., CNRS Senior Scientist, Mass Spectrometry for Biology (MSBio) Laboratory, Institut Pasteur, Paris, France

16:25 - 16:50 Structural Architecture of the Human Dolichol Synthesis Machinery
Petr Man, Ph.D., Researcher, Institute of Microbiology of the Czech Academy of Sciences, Vestec, Czech Republic

16:50 - 17:15 TBD
Stefan Kempa, Ph.D., Group Leader Proteomics and Metabolomics, Max-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin, Germany

17:15 - 18:30 Networking

Day 2: Thursday, April 16, 2026

9:00 - 9:25 MALDI-MSI strategies to visualise elusive and low abundance lipid species: Endocannabinoids
Eduardo Maria Sommella, Ph.D., Associate Professor, Medicinal Chemistry, Department of Pharmacy, University of Salerno, Salerno, Italy

9:25 - 9:50 Integrating Spatial Transcriptomics and Mass Spectrometry Imaging to uncover gene-metabolite interactions across cell populations in pulmonary fibrosis
Achim Buck, Ph.D., Clin Pharm & Noncl Safety, Global Drug Metabolism and Pharmakokinetics, Boehringer Ingelheim Pharma GmbH, Biberach an der Riss, Germany

9:50 - 10:15 Towards structural glycoproteomics
Hans JCT Wessels, PhD, Director Radboudumc Technology Center for Mass Spectrometry, Radboud University Medical Center, Nijmegen, The Netherlands

10:15 - 10:55 Coffee Break 

10:55 - 11:20 Eludication of the blood-ascites-tissue axis and peritoneal metastasis in ovarian cancer by multimodal metabolomics
Christoph Trautwein, Ph.D., Director Core Facility Metabolomics, University of Tübingen Hospital/M3 Research Center, Tübingen, Germany

11:20 - 11:45 Antibody-Free Technologies for absolute Biomarker Quantification in Human Plasma
Marie Beigel, MSc., NBE Analytical R&D, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany

11:45 - 12:10 Investigating the effects of prebiotics on the gut microbiome using metaproteomics
Morten Danielsen, Ph.D., Global Metabolomics Lead, Cmbio, Copenhagen, Denmark

12:10 - 13.40 Lunch Break

13:40 - 14:05 MALDI Multiplexed spatial screening of lipid nanoparticles for in vivo mRNA targeting
Dr. Thomas Enzlein, Group Leader Bioinformatics, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

14:05 - 14:30 MS-based functional assays, proteomics and integrative structural biology
Julian Langer, Ph.D., Head of Mass Spectrometry, Max Planck Institute of Biophysics, Frankfurt, Germany

14:30 - 14:55 TBD
TBD

14:55 - 15:10 Wrap-Up